Non-Latin European descent could be a requirement for association of NTDs and MTHFR variant 677C > T: A meta-analysis

American Journal of Medical Genetics, Part A

Volumn 143, Issue 15, 2007, Pages 1726-1732

  Amorim, Márcia R ^a   Lima, Marcelo A C ^a,b   Castilla, Eduardo E ^c,d   Orioli, Iêda M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c CEMIC   (Argentina)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

5,10 methylenetetrahydrofolate reductase; Irish population; Meta analysis; Neural tube defects; Variant 677C > T

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ARTICLE; ETHNICITY; EUROPE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HISPANIC; HUMAN; MTHFR GENE; NEURAL TUBE DEFECT; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

CONTINENTAL POPULATION GROUPS; EUROPE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NEURAL TUBE DEFECTS; POLYMORPHISM, SINGLE NUCLEOTIDE; VARIATION (GENETICS);

EID: 34547678487     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.31812     Document Type: Article

References (61)

1. Akar N, Akar E, Deda G, Arsan S. 2000. Spina bifida and common mutations at the homocysteine metabolism pathway. Clin Genet 57:230-231.
2. Barber R, Shalat S, Hendricks K, Joggerst B, Larsen R, Suarez L, Finnell R. 2000. Investigation of folate pathway gene polymorphisms and the incidence of neural tube defects in a Texas hispanic population. Mol Genet Metab 70:45-52.
3. Bjorke Monsen AL, Ueland PM, Schneede J, Vollset SE, Refsum H. 1997. Elevated plasma total homocysteine and C677T mutation of the methylenetetrahydrofolate reductase gene in patients with spina bifida. QJM 90:593-596.
4. Boduroglu K, Alikasifoglu M, Anar B, Tuncbilek E. 1999. Association of the 677C > T mutation on the methylenetetrahydrofolate reductase gene in Turkish patients with neural tube defects. J Child Neurol 14:159-161.
5. Botto LD, Yang Q. 2000. 5,10 Methylenetetrahydrofolate reductase gene variants and congenital anomalies a HuGe review. Am J Epidemiol 151:862-877.
6. Bradburn MJ, Deeks JJ, Altman DG. 1998. "Metan" an alternative meta-analysis command. Stata Technical Bulletin 44:4-15 (sbe24).
7. Castilla EE, Paz JE, Orioli-Parreiras IM. 1980. Syndactyly: Frequency of specific types. Am J Med Genet 5:357-364.
8. Christensen B, Arbour L, Tran P, Leclerc D, Sabbaghian N, Platt R, Gilfix BM, Rosenblatt DS, Gravel RA, Forbes P, Rozen R. 1999. Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase folate levels in red blood cells and risk of neural tube defects. Am J Med Genet 84:151-157.
9. Cunha AL, Hirata MH, Kim CA, Guerra Shinohara EM, Nonoyama K, Hirata RD. 2002. Metabolic effects of C677T and A1298C mutations at the MTHFR gene in Brazilian children with neural tube defects. Clin Chim Acta 318:139-143.
10. Czeizel AE, Dudas I. 1992. Prevention of first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832-1835.
11. Davalos IP, Olivares N, Castillo MT, Cantu JM, Ibarra B, Sandoval L, Moran MC, Gallegos MP, Chakraborty R, Rivas F. 2000. The C677T polymorphism of the methylenetetrahydrofolate reductase gene in Mexican mestizo neural tube defect parents control mestizo and native populations. Ann Genet 43:89-92.
12. de Franchis R, Buoninconti A, Mandato C, Pepe A, Sperandeo MP, Del Gado R, Capra V, Salvaggio E, Andria G, Mastroiacovo P. 1998. The C677T mutation of the 5,10 methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy. J Med Genet 35:1009-1013.
13. Elwood JM, Little J, Elwood JH. 1992. Epidemiology and Control of Neural Tube Defects. Oxford: Oxford University Press. p 96-167
14. Felix TM, Leistner S, Giugliani R. 2004. Metabolic effects and the methylenetetrahydrofolate reductase MTHFR polymorphism associated with neural tube defects in southern Brazil. Birth Defects Res A Clin Mol Teratol 70:459-463.
15. Garcia-Fragoso L, Garcia-Garcia I, de L, Renta J, Cadilla CL. 2002. Presence of the 5,10 methylenetetrahydrofolate reductase C677T mutation in Puerto Rican patients with neural tube defects. J Child Neurol 17:30-32.
16. Gonzalez-Herrera L, Garcia-Escalante G, Castillo-Zapata I, Canto-Herrera J, Ceballos-Quintal J, Pinto-Escalante D, Diaz-Rubio F, Del Angel RM, Orozco-Orozco L. 2002. Frequency of the thermolabile variant C677T in the MTHFR gene and lack of association with neural tube defects in the State of Yucatan Mexico. Clin Genet 62:394-398.
17. Gos M, Sliwerska E, Szpecht Potocka A. 2004. Mutation incidence in folate metabolism genes and regulatory genes in Polish families with neural tube defects. J Appl Genet 45:363-368.
18. Grandone E, Corrao AM, Colaizzo D, Vecchione G, Girgenti CD, Paladini D, Sardella L, Pellegrino M, Zelante L, Martinelli P, Margaglione M. 2006. Homocysteine metabolism in families from southern Italy with neural tube defects role of genetic and nutritional determinants. Prenat Diagn 26:1-5.
19. Gucciardi E, Pietrusiak MA, Reynolds DL, Rouleau J. 2002. Incidence of neural tube defects In Ontario 1986-1999. CMJA 167:237-240.
20. Gueant-Rodriguez RM, Rendeli C, Namour B, Venuti L, Romano A, Anello G, Bosco P, Debard R, Gerard P, Viola M, Salvaggio E, Gueant JL. 2003. Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects in humans. Neurosci Lett 344:189-192.
21. Gutierrez-Revilla JI, Perez-Hernandez F, Calvo-Martin MT, Tamparillas-Salvador M, Gracia-Romero J. 2003. C677T and A1298C MTHFR polymorphisms in the etiology of neural tube defects in Spanish population. Med Clin (Barc) 120:441-445.
22. Hill EW, Jobling MA, Bradley DG. 2000. Y chromosome variation and Irish origins. Nature 404:351-352.
23. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. 2001. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 285:2981-2986.
24. Isotalo PA, Wells GA, Donnelly JG. 2000. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms an examination of C677T and A1298C mutations. Am J Hum Genet 67:986-990.
25. Johanning GL, Tamura T, Johnston KE, Wenstrom KD. 2000. Comorbidity of 5,10 methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms and risk for neural tube defects. J Med Genet 37:949-951.
26. Kirke PN, Mills JL, Molloy A, Brody LC, O'Leary VB, Daly L, Murray S, Conley M, Mayne PD, Smith O, Scott JM. 2004. Impact of the MTHFR C677T polymorphism on risk of neural tube defects: Case-control study. BMJ 328:1535-1536.
27. Koch MC, Stegmann K, Ziegler A, Schroter B, Ermert A. 1998. Evaluation of the MTHFR C677T allele and the MTHFR gene locus in a German spina bifida population. Eur J Pediatr 157:487-492.
28. Lee BH, Cheong HI, Shin YS, Cho BK, Wang KC. 2000. The effect of C677T mutation of methylene tetrahydrofolate reductase gene and plasma folate level on hyperhomocysteinemia in patients with meningomyelocele. Childs Nerv Syst 16:559-563.
29. Lopez-Camelo JS, Orioli IM, Dutra MG, Nazer J, Wettig E, Fontanaz AM, Mellado C, Castilla EE. 2005. Reduction of birth prevalence rates of neural tube defects after folic acid fortification in Chile. Am J Med Genet Part A 135A:120-125.
30. Melnick M, Marazita ML. 1998. Neural tube defects methylenetetrahydrofolate reductase mutation and north/south dietary differences in China. J Craniofac Genet Dev Biol 18:233-235.
31. Miettinen OS. 1974. Proportion of disease caused or prevented by a given exposure trait or intervention. Am J Epidemiol 99:325-332.
32. Molloy AM, Mills JL, Kirke PN, Ramsbottom D, McPartlin JM, Burke H, Conley M, Whitehead AS, Weir DG, Scott JM. 1998. Low blood folates in NTD pregnancies are only partly explained by thermolabile 5,10 methylenetetrahydrofolate reductase low folate status alone may be the critical factor. Am J Med Genet 78:155-159.
33. Moore LT, McEvoy B, Cape E, Simms K, Bradley DG. 2006. A Y chromosome signature of hegemony in Gaelic Ireland. Am J Hum Genet 78:334-338.
34. Mornet E, Muller F, Lenvoise Furet A, Delezoide AL, Col JY, Simon Bouy B, Serre JL. 1997. Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects. Hum Genet 100:512-514.
35. Morrison K, Papapetrou C, Hol FA, Mariman EC, Lynch SA, Burn J, Edwards YH. 1998. Susceptibility to spina bifida; an association study of five candidate genes. Ann Hum Genet 62:379-396.
36. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defect: Results of the Medical Research Council Vitamin Study. Lancet 338:131-137.
37. O Brien MM, Kiely M, Harrington KE, Robson PJ, Strain JJ, Flynn A. 2001. The North/South Ireland Food Consumption Survey vitamin intakes in 18-64 year old adults. Public Health Nutr 4:1069-1079.
38. Orioli I, Ribeiro MG, Castilla EE. 2003. Clinical and epidemiological studies of amniotic deformity adhesion and mutilation ADAM sequence in a South American ECLAMC population. Am J Med Genet Part A 118A:135-145.
39. Ou CY, Stevenson RE, Brown VK, Schwartz CE, Allen WP, Khoury MJ, Rozen R, Oakley GP, Adams MJ. 1996. 5,10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 63:610-614.
40. Parle McDermott A, Mills JL, Kirke PN, O Leary VB, Swanson DA, Pangilinan F, Conley M, Molloy AM, Cox C, Scott JM, Brody LC, 2003. Analysis of the MTHFR 1298A C and 677C T polymorphisms as risk factors for neural tube defects. J Hum Genet 48:190-193.
41. Perez AB, D'Almeida V, Vergani N, de Oliveira AC, de Lima FT, Brunoni D. 2003. Methylenetetrahydrofolate reductase MTHFR incidence of mutations C677T and A1298C in Brazilian population and its correlation with plasma homocysteine levels in spina bifida. Am J Med Genet Part A 119A:20-25.
42. Persad VL, Van den Hof MC, Dube JM, Zimmer P. 2002. Incidence of open neural tube defects in Nova Scotia after folic acid fortification. CMJA 167:241-245.
43. Pietrzyk JJ, Bik Multanowski M, Sanak M, Twardowska M. 2003. Polymorphisms of the 5,10 methylenetetrahydrofolate and the methionine synthase reductase genes as independent risk factors for spina bifida. J Appl Genet 44:111-113.
44. Rampersaud E, Melvin EC, Siegel D, Mehltretter L, Dickerson ME, George TM, Enterline D, Nye JS, Speer MC. Collaborative NTD Group. 2003. Updated investigations of the role of methylenetetrahydrofolate reductase in human neural tube defects. Clin Genet 63:210-214.
45. Relton CL, Wilding CS, Pearce MS, Laffling AJ, Jonas PA, Lynch SA, Tawn EJ, Burn J. 2004. Gene gene interaction in folate related genes and risk of neural tube defects in a UK population. J Med Genet 41:256-260.
46. Richter B, Stegmann K, Roper B, Boddeker I, Ngo ET, Koch MC. 2001. Interaction of folate and homocysteine pathway genotypes evaluated in susceptibility to neural tube defects NTD in a German population. J Hum Genet 46:105-109.
47. Sadewa AH, Sutomo R, Istiadjid M, Nishiyama K, Shirakawa T, Matsuo M, Nishio H. 2004. C677T mutation in the MTHFR gene was not found in patients with frontoethmoidal encephalocele in East Java Indonesia. Pediatr Int 46:409-414.
48. Schneider JA, Rees DC, Liu YT, Clegg JB. 1998. Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. Am J Hum Genet 62:1258-1260.
49. Shaw GM, Rozen R, Finnell RH, Wasserman CR, Lammer EJ. 1998. Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida. Am J Epidemiol 148:30-37.
50. Shields DC, Kirke PN, Mills JL, Ramsbottom D, Molloy AM, Burke H, Weir DG, Scott JM, Whitehead AS. 1999. The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet 64:1045-1055.
51. Stegmann K, Ziegler A, Ngo ET, Kohlschmidt N, Schroter B, Ermert A, Koch MC. 1999. Linkage disequilibrium of MTHFR genotypes 677C/T 1298A/C in the German population and association studies in probands with neural tube defects NTD. Am J Med Genet 87:23-29.
52. Ubbink JB, Christianson A, Bester MJ, Van Allen MI, Venter PA, Delport R, Blom HJ, van der Merwe A, Potgieter H, Vermaak WJ. 1999. Folate status homocysteine metabolism and methylene tetrahydrofolate reductase genotype in rural South African blacks with a history of pregnancy complicated by neural tube defects. Metabolism 48:269-274.
53. Van der Put NMJ, Gabreels F, Stevens EMB, Smeitink JAM, Trijbels FJM, Eskes T, van den Heuvel LP, Blom HJ. 1998. A second mutation in the methylenetetrahydrofolate reductase gene an additional risk factor for neural tube defects. Am J Hum Genet 62:1044-1051.
54. Volcik KA, Blanton SH, Tyerman GH, Jong ST, Rott EJ, Page TZ, Romaine NK, Northrup H. 2000. Methylenetetrahydrofolate reductase and spina bifida evaluation of level of defect and maternal genotypic risk in Hispanics. Am J Med Genet 95:21-27.
55. Volcik KA, Blanton SH, Northrup H. 2001. Examinations of methylenetetrahydrofolate reductase C677T and A1298C mutations and in utero viability. Am J Hum Genet 69:1150-1153.
56. Vollset SE, Botto LD. 2005. Neural tube defects, other congenital malformations and single nucleotide polymorphisms in the 5,10 Methylenetetrahidrofolate reductase (MTHFR) gene: A meta-analysis. In: Ueland PM, Rozen R, editors. MTHFR Polymorphism and Disease. Georgetow: Landes Bioscience. p 125-143.
57. Wenstrom KD, Johanning GL, Owen J, Johnston KE, Acton S, Cliver S, Tamura T. 2000. Amniotic fluid homocysteine levels 5,10 methylenetetrahydrafolate reductase genotypes and neural tube closure sites. Am J Med Genet 90:6-11.
58. Whitehead AS, Gallagher P, Mills JL, Kirke PN, Burke H, Molloy AM, Weir DG, Shields DC, Scott JM. 1995. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. QJM 88:763-766.
59. Wilcken B, Bamforth F, Li Z, Zhu H, Ritvanen A, Renlund M, Stoll C, Alembik Y, Dott B, Czeizel AE, Gelman Kohan Z, Scarano G, Bianca S, Ettore G, Tenconi R, Bellato S, Scala I, Mutchinick OM, Lopez MA, de Walle H, Hofstra R, Joutchenko L, Kavteladze L, Bermejo E, Martinez-Frias ML, Gallagher M, Erickson JD, Vollset SE, Mastroiacovo P, Andria G, Botto LD. 2003. Geographical and ethnic variation of the 677C T allele of 5 10 methylenetetrahydrofolate reductase MTHFR findings from over 7000 newborns from 16 areas world wide. J Med Genet 40:619-625.
60. Yamada K, Chen Z, Rozen R, Matthews RG. 2001. Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci USA 98:14853-14858.
61. Zetterberg H, Regland B, Palmer M, Ricksten A, Palmqvist L, Rymo L, Arvanitis DA, Spandidos DA, Blennow K. 2002. Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos. Eur J Hum Genet 10:113-118.